Eride Quarta got the prestigious EUFEPS Women in Pharmaceutical Sciences Award 2021. The Women in Pharmaceutical Sciences (WIPS) initiative was established in 2017 by EUFEPS, European Federation of Pharmaceutical Sciences, with the aim of supporting the research of woman researchers, also facilitating international mobility and active participation in congresses.
Read more “TO DR ERIDE QUARTA THE PRESTIGIOUS EUFEPS WOMEN IN PHARMACEUTICAL SCIENCE AWARD 2021”
Paolo Colombo, Emeritus of the University of Parma and CEO of PlumeStars, has been named among the top 60 industrial leaders in The Medicine Maker’s Power List 2021.
The Medicine Maker is an authoritative medical-scientific magazine that constantly publishes articles and sector news promoting the medical-pharmaceutical scientific culture in the world.
On 22nd and 29th April 2021, PlumeStars organizes the Two day web course “Quality by Design in Pharmaceutical and Food Development. Theory and case studies”.
On 28 February 2021, the World Day of Rare Diseases was celebrated, a very significant celebration, which, since 2008, has contributed to keep the attention on rare diseases high and to “turn on the light” on them, as per the slogan chosen by UNIAMO (Federation of Associations of People with Rare Diseases of Italy).
PlumeStars is pleased to annonuce that has been selected for participating at the important X-HUB TOKYO’S INBOUND PROGRAM 2021.
X-HUB TOKYO’S INBOUND PROGRAM, sponsored by the Tokyo Metropolitan Government, is an accelerator program that provides opportunities for global startups in the field of FinTech, Mobility, and Life Science to enter Tokyo market.
Prof. Paolo Colombo, CEO of PlumeStars srl, has been invited to enter in the rExpert committee of the research project called AEROPERF. The project will take place in Liège, Belgium, subsidized by the Wallon Region. The Expert Committee included Prof. Nicolas Tsapis of Paris-Sud University and Marco Laackmann of Haro Hofliger.
Read more “Prof. Paolo Colombo invited in the Expert Committee of AEROPERF research project”
We are pleased to announce that PlumeStars has received the certification “Seal of Excellence” delivered by the European Commission, as the institution managing Horizon 2020, the EU Framework Programme for Research and Innovation 2014-2020.
Read more “Hyalcis’s SEAL OF EXCELLENCE certificate by the European Commission”
We are pleased to announce that the Controlled Release Society (CRS) has announced the election of Paolo Colombo, Pharm. D., Ph.D., CEO of PlumeStars, Emeritus Professor, Department of Food and Drug, University of Parma, Italy to its College of Fellows.
Read more “PAOLO COLOMBO ELECTED INTO CONTROLLED RELEASE SOCIETY (CRS) COLLEGE OF FELLOWS”
We are pleased to announce that The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Paolo Colombo, Pharm. D., Ph.D., CEO of PlumeStars, Emeritus Professor, Department of Food and Drug, University of Parma, Italy to its College of Fellows.
Read more “Paolo Colombo Inducted into Medical and Biological Engineering Institute (AIMBE)”
